Dual-optic accommodating IOL earns European CE Mark

Europe's CE Mark was given to the dual-optic accommodating IOL (Synchrony, Visiogen Inc.) for cataract and refractive surgery. The new designation will allow the company to "expand into post-marketing research studies within Europe to build the scientific foundation further for Synchrony," said Reza Zadno, PhD, Visiogen president and chief executive officer.

The system, including a dual-optic lens and pre-loaded injector, is self-contained and does not require lens handling. The lens can be inserted through a 3.6- to 3.8-mm clear-corneal incision. The single-piece silicone lens unfolds in the eye upon insertion and features two optics connected by a spring system. The springs connect a 5.5-mm high-power anterior optic and a 6-mm negative power posterior optic. The spring action moves the front optic and changes the focus from near to far. The positive- and negative-powered optics are customized for each patient.

The FDA is currently conducting a clinical study on this lens.